查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1455258

2024 年鼻内给药装置全球市场报告

Intranasal Drug Delivery Devices Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

鼻内给药装置的市场规模预计在未来几年将显着成长。预计到 2028 年将以 8.8% 的复合年增长率 (CAGR) 增长至 845.1 亿美元。预测期内的预期增长是由老年人口增加、全球呼吸系统疾病增加、神经系统疾病应用扩大、个人化医疗趋势、预防性医疗保健倡议以及新兴经济体市场推动的。这可归因于以下几个因素，包括渗透。预测期内预计的主要趋势包括配方技术的进步、对儿童和老年应用的日益关注、自我给药设备的增加、鼻粉吸入器的出现以及生技药品和胜肽的增长。例子包括嵌入。

慢性病盛行率的预期增加将推动未来鼻内给药装置市场的成长。慢性病持续时间超过一年，其特点是需要持续治疗，限制日常活动，可以使用鼻内给药装置进行有效管理。这些设备提供了一种非侵入性且有效的方式，将药物直接输送到受影响的区域。方法方便，促进快速吸收。例如，美国国立卫生研究院（NIH）2022年9月发布的一份报告预测，美国50岁及以上患有至少一种慢性病的人数将从71,522,000人增加99.5%。此外，复杂疾病患者数量预计将从2020年的783.04万人增加到2050年的1,496.8万人，成长91.16%。因此，慢性病盛行率的增加是成长背后的动力。鼻内给药装置市场。

对非侵入性药物输送方法的需求不断增长预计也将有助于鼻内药物输送装置市场的扩大。非侵入性药物输送涉及将药物给药到体内，而不需要穿透或切开皮肤或黏膜。鼻内给药装置在促进这种方法中发挥关键作用，使透过鼻子给药变得简单且有效。这些装置利用鼻子广泛的血管网络并确保快速吸收，提高了药物的生物利用度，提高了患者的依从性，并消除了侵入性手术的需要。例如，2023 年 8 月美容协会的资料显示，美国的非手术治疗显着增加，身体轮廓、皮肤治疗、毒素和微针治疗分别增加了 31%、26%、24% 和 23%。因此，对非侵入式给药方法的需求不断增长是鼻内给药装置市场扩张的主要驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球鼻内给药装置市场驱动因素与阻碍因素
    • 市场驱动力
    • 市场限制
  • 2018-2023年全球鼻内给药装置市场规模、表现与成长
  • 2023-2028年、2033年全球鼻内给药装置市场规模及成长预测

第六章市场区隔

  • 全球鼻内给药装置市场，依产品、性能及预测细分，2018-2023、2023-2028、2033
  • 送粉装置
  • 供液装置
  • 加压定量吸入器
  • 其他产品
  • 全球鼻内给药装置市场，依剂量、效能及预测细分，2018-2023、2023-2028、2033
  • 单位剂量
  • 多剂量
  • 全球鼻内给药装置市场，按应用、性能和预测细分，2018-2023、2023-2028、2033
  • 慢性阻塞性肺病（COPD）
  • 鼻炎
  • 囊肿纤维化
  • 鼻塞
  • 气喘
  • 其他用途
  • 全球鼻内给药装置市场，依最终用户细分、绩效和预测，2018-2023、2023-2028、2033
  • 医院
  • 诊所
  • 居家护理
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球鼻内给药装置市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球鼻内给药装置市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 鼻内给药装置市场竞争格局
  • 鼻内给药装置市场公司概况
    • Johnson and Johnson Inc.
    • Merck and Co.Inc.
    • Novartis AG
    • AstraZeneca plc.
    • GlaxoSmithKline Plc

第三十一章 其他重大及创新企业

  • 3M Company
  • Becton, Dickinson and Company
  • Teva Pharmaceutical Industries Ltd.
  • AptarGroup Inc.
  • West Pharmaceutical Services Inc.
  • Teleflex Incorporated
  • Recipharm AB
  • Nemera Development SA
  • Consort Medical plc.
  • Vectura Group plc
  • Douglas Pharmaceuticals Ltd.
  • Avanir Pharmaceuticals
  • OptiNoset Inc.
  • Flamel Technologies
  • Aegis Therapeutics LLC

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r16259

Intranasal drug delivery devices are medical instruments designed to administer medications into the nasal cavity. These devices are specifically created to deliver medications directly to the highly vascularized nasal mucosa, which boasts a substantial surface area, facilitating rapid absorption of the drug into the bloodstream. Intranasal drug delivery devices are capable of delivering drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity.

The primary products within the realm of intranasal drug delivery devices include powder delivery devices, liquid delivery devices, pressurized metered-dose inhalers, and other related devices. Powder delivery devices, a subtype of medical or pharmaceutical devices, are designed for administering medications in unit-dose or multi-dose forms and find applications in various medical conditions such as chronic obstructive pulmonary disease (COPD), rhinitis, cystic fibrosis, nasal congestion, asthma, among others. The end users of these devices include hospitals, clinics, homecare, and other healthcare settings.

The intranasal drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides intranasal drug delivery devices market statistics, including intranasal drug delivery devices industry global market size, regional shares, competitors with a intranasal drug delivery devices market share, detailed intranasal drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the intranasal drug delivery devices industry. This intranasal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intranasal drug delivery devices market size has grown strongly in recent years. It will grow from $55.27 billion in 2023 to $60.27 billion in 2024 at a compound annual growth rate (CAGR) of 9.0%. The growth observed in the historical period can be attributed to several factors, including an increase in chronic respiratory diseases, elevated patient preference and compliance, the convenience of self-administration, applications in pediatrics, market expansion in allergic rhinitis treatment, and a broader range of indications.

The intranasal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $84.51 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing geriatric population, a rise in global respiratory issues, expanding applications in neurological disorders, trends in personalized medicine, initiatives in preventive healthcare, and market penetration in emerging economies. Major trends expected in the forecast period include advances in formulation technologies, a heightened focus on pediatric and geriatric applications, an increase in self-administration devices, the emergence of nasal powder inhalers, and the incorporation of biologics and peptides.

The anticipated rise in the prevalence of chronic diseases is poised to drive the growth of the intranasal drug delivery devices market in the future. Chronic diseases, characterized by lasting for a year or more and requiring ongoing medical attention that limits daily activities, can be effectively managed using intranasal drug delivery devices. These devices offer a non-invasive and efficient means of administering medications, delivering them directly to the affected area. This method is both convenient and promotes rapid absorption. For instance, a report published by the National Institutes of Health (NIH) in September 2022 indicated that in the United States, the number of individuals aged 50 and older with at least one chronic illness is projected to increase by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity is expected to rise by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Hence, the increasing prevalence of chronic diseases is a driving factor for the growth of the intranasal drug delivery devices market.

The growing demand for non-invasive drug delivery methods is also expected to contribute to the expansion of the intranasal drug delivery device market. Non-invasive drug delivery involves administering pharmaceutical substances into the body without the need for skin or mucous membrane penetration or incision. Intranasal drug delivery devices play a crucial role in facilitating this approach, making it easy and effective to administer drugs through the nose. Leveraging the nose's extensive blood vessel network and ensuring fast absorption, these devices enhance drug bioavailability, improve patient adherence, and eliminate the need for invasive procedures. For example, data from The Aesthetic Society in August 2023 highlighted a significant increase in nonsurgical procedures in the U.S., with body contouring, skin treatment, toxins, and micro-needling showing growth rates of 31%, 26%, 24%, and 23%, respectively, in 2022. As a result, the growing demand for non-invasive drug delivery methods is a key driver for the expansion of the intranasal drug delivery device market.

The anticipated risk of nasal irritation and other adverse effects is expected to act as a constraint on the growth of the intranasal drug delivery device market. Concerns regarding potential discomfort and safety issues may impede widespread acceptance and adoption of these devices for non-invasive drug delivery. As an example, data from the Centers for Disease Control and Prevention (CDC) in January 2022 revealed that 28.9 million adults in the United States, accounting for 11.6% of the adult population, had been diagnosed with sinusitis. Sinusitis leads to approximately 73 million restricted activity days annually. Consequently, the perceived risk of nasal irritation and other adverse effects may hinder the growth of the intranasal drug delivery device market.

Major pharmaceutical companies in the nasal drug delivery technology market are actively engaged in developing new and improved products to offer innovative drug administration methods and maintain their market position. For instance, in January 2023, AptarGroup, Inc., a US-based drug delivery and pharmaceutical company, introduced APF Futurity, the first recyclable, metal-free, multidose nasal spray for delivering nasal saline and similar over-the-counter (OTC) formulations. This product, made from polyolefin materials and devoid of metal components or recycling disruptors, reduces the need for separation in recycling streams and supports a higher grade of recycled materials. Notably, APF Futurity is a highly recyclable nasal spray pump that has obtained Class AA certification from cyclos-HTP for recycling streams in Europe.

In March 2022, Sandoz AG, a Switzerland-based biopharmaceutical company under the Novartis Group, acquired Coalesce Product Development Limited for an undisclosed amount. This strategic move aims to enhance Sandoz's capabilities in inhalation drug delivery, add a commercial-stage product to its portfolio, and expedite the development and commercialization of intranasal drug delivery devices. Coalesce Product Development Limited, based in the UK, specializes in drug delivery device development, including nasal drug delivery.

Major companies operating in the intranasal drug delivery devices market report are Johnson and Johnson Inc., Merck and Co.Inc., Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd., AptarGroup Inc., West Pharmaceutical Services Inc., Teleflex Incorporated, Recipharm AB, Nemera Development S.A., Consort Medical plc., Vectura Group PLC, Douglas Pharmaceuticals Ltd., Avanir Pharmaceuticals, OptiNoset Inc., Flamel Technologies, Aegis Therapeutics LLC, Sonoma Pharmaceuticals, PendoPharm Inc., Kurve Technology Inc., Impel NeuroPharma, Impexium Medical Products, B.F. Ascher and Company Inc., ENT Technologies Pty. Ltd., Neurelis Inc., Generex Biotechnology Corporation

North America was the largest region in the intranasal drug delivery devices market in 2023. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intranasal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The intranasal drug delivery devices market consists of sales of nasal sprays, nasal powder devices, nasal antipsychotic medications, nasal epinephrine devices, nasal drops, and nasal inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intranasal Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intranasal drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intranasal drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intranasal drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Powder Delivery Device; Liquid Delivery Device; Pressurized Metered-Dose Inhalers; Other Products
  • 2) By Dosage: Unit-Dose; Multi-Dose
  • 3) By Application: Chronic Obstructive Pulmonary Disease (COPD); Rhinitis; Cystic Fibrosis; Nasal Congestion; Asthma; Other Applications
  • 4) By End User: Hospitals; Clinics; Homecare; Other End Users
  • Companies Mentioned: Johnson and Johnson Inc.; Merck and Co.Inc.; Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intranasal Drug Delivery Devices Market Characteristics

3. Intranasal Drug Delivery Devices Market Trends And Strategies

4. Intranasal Drug Delivery Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Intranasal Drug Delivery Devices Market Size and Growth

  • 5.1. Global Intranasal Drug Delivery Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Intranasal Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Intranasal Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Intranasal Drug Delivery Devices Market Segmentation

  • 6.1. Global Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Powder Delivery Device
  • Liquid Delivery Device
  • Pressurized Metered-dose Inhalers
  • Other Products
  • 6.2. Global Intranasal Drug Delivery Devices Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Unit-Dose
  • Multi-Dose
  • 6.3. Global Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Rhinitis
  • Cystic Fibrosis
  • Nasal Congestion
  • Asthma
  • Other Applications
  • 6.4. Global Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Homecare
  • Other End Users

7. Intranasal Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Intranasal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Intranasal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Intranasal Drug Delivery Devices Market

  • 8.1. Asia-Pacific Intranasal Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Intranasal Drug Delivery Devices Market

  • 9.1. China Intranasal Drug Delivery Devices Market Overview
  • 9.2. China Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Intranasal Drug Delivery Devices Market

  • 10.1. India Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Intranasal Drug Delivery Devices Market

  • 11.1. Japan Intranasal Drug Delivery Devices Market Overview
  • 11.2. Japan Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Intranasal Drug Delivery Devices Market

  • 12.1. Australia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Intranasal Drug Delivery Devices Market

  • 13.1. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Intranasal Drug Delivery Devices Market

  • 14.1. South Korea Intranasal Drug Delivery Devices Market Overview
  • 14.2. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Intranasal Drug Delivery Devices Market

  • 15.1. Western Europe Intranasal Drug Delivery Devices Market Overview
  • 15.2. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Intranasal Drug Delivery Devices Market

  • 16.1. UK Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Intranasal Drug Delivery Devices Market

  • 17.1. Germany Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Intranasal Drug Delivery Devices Market

  • 18.1. France Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Intranasal Drug Delivery Devices Market

  • 19.1. Italy Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Intranasal Drug Delivery Devices Market

  • 20.1. Spain Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Intranasal Drug Delivery Devices Market

  • 21.1. Eastern Europe Intranasal Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Intranasal Drug Delivery Devices Market

  • 22.1. Russia Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Intranasal Drug Delivery Devices Market

  • 23.1. North America Intranasal Drug Delivery Devices Market Overview
  • 23.2. North America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Intranasal Drug Delivery Devices Market

  • 24.1. USA Intranasal Drug Delivery Devices Market Overview
  • 24.2. USA Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Intranasal Drug Delivery Devices Market

  • 25.1. Canada Intranasal Drug Delivery Devices Market Overview
  • 25.2. Canada Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Intranasal Drug Delivery Devices Market

  • 26.1. South America Intranasal Drug Delivery Devices Market Overview
  • 26.2. South America Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Intranasal Drug Delivery Devices Market

  • 27.1. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Intranasal Drug Delivery Devices Market

  • 28.1. Middle East Intranasal Drug Delivery Devices Market Overview
  • 28.2. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Intranasal Drug Delivery Devices Market

  • 29.1. Africa Intranasal Drug Delivery Devices Market Overview
  • 29.2. Africa Intranasal Drug Delivery Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Intranasal Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Intranasal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Intranasal Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Intranasal Drug Delivery Devices Market Competitive Landscape
  • 30.2. Intranasal Drug Delivery Devices Market Company Profiles
    • 30.2.1. Johnson and Johnson Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck and Co.Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Novartis AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AstraZeneca plc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlaxoSmithKline Plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Intranasal Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. 3M Company
  • 31.2. Becton, Dickinson and Company
  • 31.3. Teva Pharmaceutical Industries Ltd.
  • 31.4. AptarGroup Inc.
  • 31.5. West Pharmaceutical Services Inc.
  • 31.6. Teleflex Incorporated
  • 31.7. Recipharm AB
  • 31.8. Nemera Development S.A.
  • 31.9. Consort Medical plc.
  • 31.10. Vectura Group plc
  • 31.11. Douglas Pharmaceuticals Ltd.
  • 31.12. Avanir Pharmaceuticals
  • 31.13. OptiNoset Inc.
  • 31.14. Flamel Technologies
  • 31.15. Aegis Therapeutics LLC

32. Global Intranasal Drug Delivery Devices Market Competitive Benchmarking

33. Global Intranasal Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Intranasal Drug Delivery Devices Market

35. Intranasal Drug Delivery Devices Market Future Outlook and Potential Analysis

  • 35.1 Intranasal Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Intranasal Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Intranasal Drug Delivery Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer